Table 2.
Review of Inherited Human Diseases Caused by Impaired GPCR Function
Characteristic | Receptor − Phenotypes: Loss-of-Function Mutation | Receptor + Phenotypes: Gain-of-Function Mutation | Gαs − Phenotypes: Loss-of-Function Mutation/Maternal Imprinting | Gαs + Phenotypes: Gain-of-Function Mutation + |
---|---|---|---|---|
LHCGR | Leydig cell hypoplasia (male) | Precocious puberty (male) | Unknown | Precocious puberty (McCune-Albright syndrome), male + female |
Hypergonadotrophic hypogonadism (male and female) | Leydig cell adenoma (male) | |||
TSHR | Congenital hypothyroidism | Nonautoimmune hyperthyroidism | Hyperthyrotropinemia | Hyperthyroidism (McCune-Albright syndrome) |
Hyperthyrotropinemia | Thyroid adenoma | Hypothyroidism | Thyroid adenoma | |
PTH1R | Blomstrand chondrodysplasia | Jansen metaphyseal chondrodysplasia | Albright hereditary osteodystrophy | New: this report (F376V) |
Pseudohypoparathyroidism | Fibrous dysplasia (MAS) | |||
V2R | X-linked nephrogenic diabetes insipidus | NSIAD | Unknown | New: NSIAD this report (F376V) |
Human diseases caused by variants of GPCR or Gαs of either loss- or gain-of-function consequences, including the novel phenotypes caused by variant p.F376V studied in this report. Boldface indicates phenotypes of the patients in this study. Receptor +/Gαs + = gain-of-function variants; Receptor −/Receptor − = loss-of-function variants.
Abbreviation: MAS, McCune-Albright syndrome.